PF-06471553
PF-06471553 Basic information
- Product Name:
- PF-06471553
- Synonyms:
-
- PF-06471553
- PF 06471553,PF06471553
- 1H-Isoindole-5-sulfonamide, N-(2-cyclobutyl-2H-1,2,3-triazol-4-yl)-2,3-dihydro-2-[2-(3-methoxyphenyl)acetyl]-
- CAS:
- 1808094-07-6
- MF:
- C23H25N5O4S
- MW:
- 467.54
- Mol File:
- 1808094-07-6.mol
PF-06471553 Chemical Properties
- Boiling point:
- 728.7±70.0 °C(Predicted)
- Density
- 1.46±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO : ≥ 150 mg/mL (320.83 mM)
- form
- Solid
- pka
- 6.75±0.20(Predicted)
- color
- White to off-white
PF-06471553 Usage And Synthesis
Description
PF-06471553 is a potent and selective Monoacylglycerol acyltransferase 3 (MGAT3) inhibitor. PF-06471553 selectively inhibits MGAT3 with high in vitro potency and cell efficacy. In the presence of a combination of diacylglycerol acyltransferases 1 and 2 (DGAT1 and DGAT2) inhibitors, an oral administration of PF-06471553 exhibited inhibition of the incorporation of deuterium-labeled glycerol into TAG in mouse model. Inhibition of triacylglycerol (TAG) biosynthetic enzymes has been suggested as a promising strategy to treat insulin resistance, diabetes, dyslipidemia, and hepatic steatosis.
Uses
PF-06471553 is a potent, selective and orally available monoacylglycerol acyltransferase 3 (MGAT3) inhibitor, with an IC50 of 92 nM.
in vivo
PF-06471553 (200 mg/kg, p.o.) in addition with (DGAT1 and DGAT2) inhibitors shows additional inhibition of glycerol-d5 incorporated triolein in hMGAT3 mice, and with no effect on WT mice[1].
References
[1] Huard K, et al. Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3. J Med Chem. 2015 Sep 24;58(18):7164-72. DOI:10.1021/acs.jmedchem.5b01008
PF-06471553Supplier
- Tel
- 18652989687
- sales@norris-pharm.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 13006575422@163.com
- Tel
- 010-50973130 18101056239
- 3193328036@qq.com
- Tel
- jnyaoyan@163.com